Inflammation is central to the progression of NAFLD, as evidenced by increased serum levels of pro-inflammatory cytokines such as TNF-α, IL-6, and IL-1β in affected individuals [41]. This evidence concerns the gene IL1B and metabolic dysfunction-associated steatotic liver disease.